Session Chair Profile
M.D., Ph.D., Chief Genomics Officer (CGO), UCSF Health
Dr. Aleksandar Rajkovic was the Professor and Marcus Allen Hogge Chair in Reproductive Sciences, the Director of the Division of Reproductive Genetics and Medical Director for the Pittsburgh Cytogenetic and Genomic Laboratories in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Pittsburgh. He recently moved to UCSF to be the Chief Genomics Officer. He serves as the Medical Director and Chief of the Center for Genetic and Genomic Medicine (CGGM) that organizes, coordinates and oversees Clinical Genetics and Genomics Services across the entire UCSF Health System. He is also Stuart Lindsay Distinguished Professor in Experimental Pathology I, member of the American Society of Clinical Investigator and American Association of Physicians. His research interests lie in basic and translational medical sciences in the area of reproductive genetics. Dr. Rajkovic discovered numerous genes that play critical roles in reproductive tract development, male and female infertility, and uterine tumors. He has been at the forefront of applying cutting edge genomic technologies to reproductive diagnostics, including prenatal diagnosis, preimplantation genetic screening, and perinatal genomics. He has made significant contributions to non-invasive diagnosis of submicroscopic deletions, design and utility of dense X chromosome arrays, and utility of genome wide detection of copy number variants in prenatal diagnosis. His current interests lie in whole genome applications towards population based health prediction and prevention, as well as elimination of Mendialian disorders.
Session Abstract – PMWC 2019 Silicon Valley
Session Synopsis: Aleks Rajkovic, Chief Genomics Officer (CGO), UCSF Health and Cornelius F. Boerkoel Executive Clinical Director of the Sanford Genetics Laboratories, Sanford Health will discuss the topics of clinical genomics within Medical Centers, different models of delivering genomic medicine, and challenges that different type of Health systems are facing with clinical genetics. They will highlight the Sanford experience, UCSF experience and touch upon current efforts and the future of clinical genomics in the context of clinical utility and validity.